NEW YORK, July 19 – Lion Bioscience said Thursday it would license software from MDL Information Systems, a developer of chemistry-based software, in order develop new applications that could then be integrated with MDL’s products.
The deal is designed to help Lion of Heidelberg, Germany to offer products across the entire life science research and development process.
The license includes MDL's ISIS, Assay Explorer, Apex, Afferent, and CrossFire Beilstein. Lion will also use these tools within its internal drug discovery unit.
In exchange, MDL of San Leandro, Calif., has been granted a license to be the exclusive reseller for Lion’s idea product line for the prediction and analysis of ADME (adsorption, distribution, metabolism, excretion).
Financial details of the agreements were not disclosed.
In April, Lion hired three executives from MDL, including Rudolph Potenzone, who is now president and CEO of Lion's US operations, Daniel Keesman, who is vice president of global sales and marketing, and Mark Canales who is senior vice president of cheminformatics development.